共 30 条
[1]
Ychou M(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-1721
[2]
Boige V(2015)Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial Lancet Oncol 16 1090-1098
[3]
Pignon JP(1996)A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462-467
[4]
Shapiro J(2017)Perioperative docetaxel, cisplatin, and 5-fuorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma Eur J Surg Oncol 43 218-225
[5]
van Lanschot JJB(2012)Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2074-2084
[6]
Hulshof MCCM(2019)Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis Gastric Cancer 22 245-254
[7]
Walsh TN(2002)Surgical management and long-term survival after adenocarcinoma of the cardia Br J Surg 89 1156-1163
[8]
Noonan N(2002)Extended transthoracic resection compared with limited transjatal resection for adenocarcinoma of the esophagus N Engl J Med 347 1662-1669
[9]
Hollywood D(2021)Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis BMC Surg 21 137-1203
[10]
Kim S(2021)Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer N Engl J Med 384 1191-undefined